• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Glob Reg Health Technol Assess . A guide to critical reading of influenza vaccine cost-effectiveness analyses

tetano

Editor, Senior Moderator
Glob Reg Health Technol Assess


. 2026 Apr 27:13:95-108.
doi: 10.33393/grhta.2026.3619. eCollection 2026 Jan-Dec.
A guide to critical reading of influenza vaccine cost-effectiveness analyses

Raúl Ortiz de Lejarazu[SUP] 1 [/SUP], Esther Redondo Margüello[SUP] 2 3 [/SUP], Ángel Gil de Miguel[SUP] 4 [/SUP], Federico Martinón Torres[SUP] 5 6 [/SUP], Javier Díez Domingo[SUP] 7 [/SUP], Juan L López-Belmonte Claver[SUP] 8 [/SUP], Ariadna Díaz-Aguiló[SUP] 8 [/SUP], J Manel Farré Avellà[SUP] 9 [/SUP], Paloma I Palomo Jiménez[SUP] 8 [/SUP], José M Abellán Perpiñán[SUP] 10 [/SUP]


Affiliations
Abstract

Introduction: Influenza vaccines are formulated each year to prevent serious illness in at-risk individuals, including elderly people. Healthcare decision-making is mainly based on the economic evaluations (EEs) (i.e., cost-effectiveness analysis [CEA]) of vaccines; however, understanding the limitations of these models and correctly interpreting the results may be challenging. Here, we provide a practical Guide that will help readers who are not experts in the field of health economics or influenza to critically review influenza vaccine EEs.
Methods: This Guide is based on the findings of a systematic review of the literature, a critical analysis of the available EEs published for influenza vaccines for older adults in Spain, and applicable national and international guidelines on EE and influenza modeling. It has been developed by a multidisciplinary board of experts in influenza, vaccines, and health economics.
Results: The guide provides tips to help the reader assess whether an EE design is fit for its purpose in terms of comparators, time horizon, perspective of the analysis, population analyzed, and whether appropriate modeling methods were applied. It detects the uncertainty arising from input data and the implications of this uncertainty on the results.
Conclusions: Ultimately, this resource aims to empower decision-makers, particularly those without expertise in health economics or vaccinology, to critically read and interpret EEs, thus favoring evidence-based informed decisions that will improve the efficiency of influenza vaccination programs.

Keywords: Critical reading; Economic evaluations; Health policy; Healthcare decision-making; Influenza vaccination.

 
Back
Top Bottom